Intra-monocyte Pharmacokinetics of Imiglucerase Supports a Possible Personalized Management of Gaucher Disease Type 1 - Université de Bretagne Occidentale Access content directly
Journal Articles Clinical Pharmacokinetics Year : 2019

Intra-monocyte Pharmacokinetics of Imiglucerase Supports a Possible Personalized Management of Gaucher Disease Type 1

Marie Pers
  • Function : Author
Ivan Bertchansky
  • Function : Author
Monia Bengherbia
  • Function : Author
Amina Berrahal
  • Function : Author
No file

Dates and versions

hal-02052295 , version 1 (28-02-2019)

Identifiers

Cite

Juliette Berger, Marie Vigan, Bruno Pereira, Thu Thuy Nguyen, Roseline Froissart, et al.. Intra-monocyte Pharmacokinetics of Imiglucerase Supports a Possible Personalized Management of Gaucher Disease Type 1. Clinical Pharmacokinetics, 2019, 58 (4), pp.469-482. ⟨10.1007/s40262-018-0708-8⟩. ⟨hal-02052295⟩
123 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More